Inhibition of angiogenesis, tumorigenesis and cathepsin...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/57 (2006.01) A61K 38/30 (2006.01) A61P 35/00 (2006.01) C07K 14/65 (2006.01) C07K 14/81 (2006.01) C12N 9/64 (2006.01)

Patent

CA 2659585

Insulin-like growth factor binding proteins (IGFBPs) and variants thereof, including IGFBP-1, IGFBP-2, IGFBP-3, IGFBP-4, IGFBP-5, IGFBP-6 and the C-terminal fragments thereof, inhibit angiogenesis, tumorigenesis and cathepsin activity, particularly cathepsin B activity.

La présente invention concerne des protéines de liaison au facteur de croissance de type insuline (IGFBP) et des variants de celles-ci, comprenant IGFBP-1, IGFBP-2, IGFBP-3, IGFBP-4, IGFBP-5, IGFBP-6 et leurs fragments C-terminal, qui inhibent l'angiogenèse, la tumorigenèse et l'activité de la cathepsine, notamment l'activité de la cathepsine B.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Inhibition of angiogenesis, tumorigenesis and cathepsin... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of angiogenesis, tumorigenesis and cathepsin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of angiogenesis, tumorigenesis and cathepsin... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1425671

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.